Buntanetap - Good summary

[ZebraDoodle]

parkinsonsnewstoday.com/bun...

Seems to reflect current status well.Next question is does anyone know about future trials?

[park_bear]

Someone commented here a while back that a planned open label extension for the Parkinson's phase 3 trial was canceled. They have got a phase 3 trial for Alzheimer's in progress but no trials for Parkinson's at this time as far as I know. A couple of weeks ago the company received a delisting notice due to low market capitalization. This is going to be hard to fix, unlike a low share price which can be fixed by reverse split. Reference: annovisbio.com/press-releas...

[MarionP]

Actually I didn't think the summary was well written at all, it was extremely "glossy" using summary and category words that were vague and biased to the positive without actually saying what it's terms meant. I kept having to ask "what do you mean by" this or that, "aimed" or "helped" etc. Also it completely ignored prior concerns about material effects on certain organs, well glossily stating "no effect 'related to treatment'. " What the heck does that mean?

[MarionP]

And then there was this... And even though a year old now, problems identified in there are still not entirely addressed:

fiercebiotech.com/biotech/a...